Cited by 143Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors

Chopra, Ian·2002·Drug Resistance Updates

DOI 10.1016/s1368-7646(02)00051-1

Open this paper in CoChat — free account

Abstract

The tetracyclines, discovered in the 1940s, are a well-established class of antibiotics that still have a role in treating microbial infections in man. However, the widespread emergence of bacterial resistance due to efflux and ribosomal protection mechanisms has severely limited their effectiveness. A new generation of tetracyclines, the glycylcyclines, has been developed to overcome resistance to earlier tetracyclines. One of the new glycylcyclines, 9-t-butylglyclamido-minocycline (GAR-936, tigecycline) is currently undergoing clinical trials. This review considers the current status of glycylcyclines and the possibility that resistance to these agents might arise in the future. Other approaches are also being taken to address the emergence of resistance to tetracyclines. Recently, a number of tetracycline efflux pump inhibitors have been discovered that might be used in combination with earlier tetracyclines to restore their activity against resistant organisms. However, the development of tetracycline efflux pump inhibitors is complicated by the occurrence of several efflux pump sub-families and by the presence of both efflux and ribosomal protection mechanisms in the same organism, especially in naturally occurring, Gram-positive clinical isolates.

Integrity signals

Registry

Crossref · 10.1016/s1368-7646(02)00051-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,466
The Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867
High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens
LeClerc, J. E., Li, B., Payne, W. L., & Cebula, T. A. (1996) · Science · doi:10.1126/science.274.5290.1208 · Cited by 818
In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P., & TESTA, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 413
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori
Björkholm, B., Sjölund, M., Falk, P. G., Berg, O. G., Engstrand, L. G., & Andersson, D. I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241517298 · Cited by 404
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301
The Pharmaceutical Industry
Cimoli, M. (2013) · Routledge eBooks · doi:10.4324/9780203056219-22 · Cited by 198
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
Gales, A. C., & Jones, R. N. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00092-9 · Cited by 189
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936
Sum, P., & Petersen, P. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173

Show all 42 references

Research works printed but not linked: 2

Finch, R.G., 1997. Tetracyclines. In: O’Grady, F., Lambert, H.P., Finch, R.G., et al. (Eds.), Antibiotic and Chemotherapy, 7th Edition. Churchill Livingstone, New York, pp. 469–484.
Nelson, M.L., 2002. Attacking the superbugs. Drug Discovery World, Spring, pp. 77–82.

Sorted by citations

Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,742
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,086
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 803
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants
Blanco, P., Hernando‐Amado, S., Reales‐Calderón, J. A., Corona, F., Lira, F., Alcalde‐Rico, M., Bernardini, A., Sánchez, M. B., & Martínez, J. L. (2016) · Microorganisms · doi:10.3390/microorganisms4010014 · Cited by 667
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 496
The A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322
Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects
Muralidharan, G., Micalizzi, M., Speth, J., Raible, D. G., & Troy, S. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.220-229.2005 · Cited by 333
Bacterial efflux systems and efflux pumps inhibitors
Marquez, B. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.012 · Cited by 269
Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 259
Potential of old-generation antibiotics to address current need for new antibiotics
Falagas, M. E., Grammatikos, A. P., & Michalopoulos, A. S. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.593 · Cited by 247
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 239
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207
The historical delivery of antibiotics from microbial natural products—Can history repeat?
Peláez, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.010 · Cited by 201
Interaction of antibacterial compounds with RND eﬄux pumps in Pseudomonas aeruginosa
Dreier, J., & Ruggerone, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00660 · Cited by 202
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily
Kumar, S. H., Mukherjee, M. M., & Varela, M. F. (2013) · International Journal of Bacteriology · doi:10.1155/2013/204141 · Cited by 167
Tigecycline: A glycylcycline antimicrobial agent
Doan, T.-L., Fung, H. B., Mehta, D., & Riska, P. F. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.011 · Cited by 152
Bacterial Efflux Pumps Involved in Multidrug Resistance and their Inhibitors: Rejuvinating the Antimicrobial Chemotherapy
Bhardwaj, A. K., & Mohanty, P. (2012) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489112799829710 · Cited by 148
Impact of metal coordination on the antibiotic and non-antibiotic activities of tetracycline-based drugs
Guerra, W., Silva, P. P., Terenzi, H. F., & Pereira-Maia, E. C. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.009 · Cited by 138
Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes
Viveiros, M., de Jesus, A. P., Brito, M., Leandro, C., Martins, M., Ordway, D. J., Molnar, A. M., Molnar, J. A., & Amaral, L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3578-3582.2005 · Cited by 135
Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936)
Hirata, T., Saito, A., Nishino, K., Tamura, N., & Yamaguchi, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2179-2184.2004 · Cited by 122
RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae
Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2006.9990 · Cited by 111
Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents
Watkins, R., Holubar, M. K., & David, M. Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01216-19 · Cited by 108
Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view
Lynch, A. S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.021 · Cited by 103
Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study
KRULWICH, T. A., Lewinson, O., Padan, E., & Bibi, E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1181 · Cited by 97
AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganii
Ruzin, A. V., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.791-793.2005 · Cited by 93
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92
Performance of Traditional and Emerging Water-Treatment Technologies in the Removal of Tetracycline Antibiotics
Wang, F., Wang, Z., Zhao, Y., & Zhang, J. (2024) · Catalysts · doi:10.3390/catal14040269 · Cited by 90
Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options
Castanheira, M., Mendes, R. E., & Jones, R. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu706 · Cited by 85
Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, H. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688949 · Cited by 84
Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for Tigecycline
Tuckman, M., Petersen, P. J., Howe, A. Y. M., Orlowski, M., Mullen, S., Chan, K., Bradford, P. A., & Jones, C. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00625-07 · Cited by 83
Tetraciclinas, sulfamidas y metronidazol
Vicente, D. A., & Pérez‐Trallero, E. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.10.002 · Cited by 80
Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution
Arenz, S., Nguyen, F., Beckmann, R., & Wilson, D. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501775112 · Cited by 75
In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus
Muniz, D. F., Barbosa, C. R. D. S., de Menezes, I. R. A., de Sousa, E. O., Pereira, R. L. S., Júnior, J. T. C., Pereira, P. S., de Matos, Y. M. L. S., da Costa, R. H. S., Oliveira–Tintino, C. D. D. M., et al. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127776 · Cited by 67
Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects
Muralidharan, G., Fruncillo, R. J., Micalizzi, M., Raible, D. G., & Troy, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1656-1659.2005 · Cited by 64
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02488-19 · Cited by 64
Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance gene tet (X4)
Zhang, S., Wen, J., Wang, Y., Wang, M., Jia, R., Chen, S., Liu, M., Zhu, D., Zhao, X., Wu, Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.969769 · Cited by 59
Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms
Garrison, M. W., Neumiller, J. J., & Setter, S. M. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.007 · Cited by 60
The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species
Chovanová, R., Mezovská, J., Vaverková, Š., & Mikulášová, M. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12424 · Cited by 59
Pharmacokinetics and Safety Profile of Tigecycline in Children Aged 8 to 11 Years With Selected Serious Infections: A Multicenter, Open-Label, Ascending-Dose Study
Purdy, J., Jouve, S., Yan, J. L., Balter, I. H., Dartois, N., Cooper, C. A., & Korth-Bradley, J. M. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.010 · Cited by 58
A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM
Robertson, G. T., Doyle, T. B., Du, Q., Duncan, L. R., Mdluli, K. E., & Lynch, A. S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00805-07 · Cited by 54
The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates
Akiyama, T., Presedo, J., & Khan, A. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.017 · Cited by 51
Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX
Volkers, G., Damas, J. M., Palm, G. J., Panjikar, S., Soares, C. M., & Hinrichs, W. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913013802 · Cited by 45
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
Chen, Z., Wu, J., Zhang, Y., Wei, J., Leng, X.-S., Bi, J., Li, R., Yan, L., Quan, Z., Chen, X., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-217 · Cited by 45
Protonation Patterns in Tetracycline:Tet Repressor Recognition: Simulations and Experiments
Aleksandrov, A. V., Proft, J., Hinrichs, W., & Simonson, T. (2007) · ChemBioChem · doi:10.1002/cbic.200600535 · Cited by 45
Natural-Product-Based Solutions for Tropical Infectious Diseases
Adegboye, O., Field, M. A., Kupz, A., Pai, S., Sharma, D., Smout, M. J., Wangchuk, P., Wong, Y., & Loiseau, C. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00348-20 · Cited by 43
NiFe2O4/biochar decorated porous polymer membranes for the flow-through photo-Fenton degradation of tetracycline
Leichtweis, J., Carissimi, É., Hagemann, U., Ulbricht, M., & Fischer, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147203 · Cited by 41
Study of a hybrid process combining PACs and membrane operations for antibiotic wastewater treatment
Zhang, J., Giorno, L., & Drioli, E. (2006) · Desalination · doi:10.1016/j.desal.2005.11.004 · Cited by 41
Enterococcus faecalis Resistant to Linezolid: Case Series and Review of the Literature
Burleson, B. S., Ritchie, D. J., Micek, S. T., & Dunne, W. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1225.38086 · Cited by 41
Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide
Moon, A., Gil, S., Gill, S. E., Chen, P., & Matute‐Bello, G. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-31 · Cited by 37
Tetracyclines, Glycylcyclines, and Chloramphenicol
Moffa, M. A., & Brook, I. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00026-6 · Cited by 40
Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
Korth-Bradley, J. M., Baird, S., Patat, A. A., Troy, S. M., Böhmer, G. M., Gleiter, C. H., Bücheler, R., & Morgan, M. Y. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010363477 · Cited by 35
Tigecycline: A Review of Properties, Applications, and Analytical Methods
da Silva, L. M., & Salgado, H. R. N. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181dda54f · Cited by 33
Comparison of Antimicrobial Resistance in Escherichia coli Strains Isolated From Healthy Poultry and Swine Farm Workers Using Antibiotics in Korea
Cho, S.-H., Lim, Y.-S., & Kang, Y.-H. (2012) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2012.07.002 · Cited by 32
Evaluation of antimicrobial activity of the hydrolate of Coridothymus capitatus (L.) Reichenb. fil. (Lamiaceae) alone and in combination with antimicrobial agents
Marino, A., Nostro, A., Mandras, N., Roana, J., Ginestra, G., Miceli, N., Taviano, M. F., Gelmini, F., Beretta, G., & Tullio, V. C. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2877-x · Cited by 32
Tetraciclinas, sulfamidas y metronidazol
Pérez‐Trallero, E., & Iglesias, L. (2003) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(03)72999-1 · Cited by 32
Tetracyclines and Chloramphenicol
Salvatore, M., & Meyers, B. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00027-8 · Cited by 31
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
Huband, M. D., Mendes, R. E., Pfaller, M. A., Lindley, J. M., Strand, G. J., Benn, V. J., Zhang, J., Li, L., Zhang, M., Tan, X., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02375-19 · Cited by 30
NorA, Tet(K), MepA, and MsrA Efflux Pumps in Staphylococcus aureus, their Inhibitors and 1,8-Naphthyridine Sulfonamides
Coutinho, H. D. M., Oliveira–Tintino, C. D. D. M., Muniz, D. F., Barbosa, C. R. D. S., Pereira, R. L. S., Begnini, I. M., Rebelo, R. A., da Silva, L. E., Mireski, S. L., Nasato, M. C., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221212101501 · Cited by 27
Tetracycline-Tet Repressor Binding Specificity: Insights from Experiments and Simulations
Aleksandrov, A. V., Schuldt, L., Hinrichs, W., & Simonson, T. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.050 · Cited by 26
Binding of Tetracyclines to Elongation Factor Tu, the Tet Repressor, and the Ribosome: A Molecular Dynamics Simulation Study
Aleksandrov, A. V., & Simonson, T. (2008) · Biochemistry · doi:10.1021/bi801726q · Cited by 24
Cloacal Lactobacillus Isolates from Broilers Often Display Resistance Toward Tetracycline Antibiotics
Cauwerts, K., Pasmans, F., Devriese, L. A., Haesebrouck, F., & Decostere, A. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.284 · Cited by 24
Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures
Bhattacharya, I., Gotfried, M. H., Ji, A., Saunders, J. P., Gourley, I. S., Diehl, A. M., & Korth-Bradley, J. M. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.201 · Cited by 22
Evaluation of a Potential Tigecycline‐Warfarin Drug Interaction
Zimmerman, J. J., Raible, D. G., Harper, D. M., Matschke, K. T., & Speth, J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.7.895 · Cited by 22
Synthesis and Antibacterial Activity of Doxycycline Neoglycosides
Zhang, J., Ponomareva, L. V., Marchillo, K., Zhou, M., Andes, D. R., & Thorson, J. S. (2013) · Journal of Natural Products · doi:10.1021/np4003096 · Cited by 20
Characterization of virulence and antimicrobial resistance genes of Aeromonas media strain SD/21–15 from marine sediments in comparison with other Aeromonas spp.
Dubey, S., Ager-Wick, E., Peng, B., Evensen, Ø., Sørum, H. R., & Munang’andu, H. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1022639 · Cited by 19
Effects of Menthol Supplementation in Feedlot Cattle Diets on the Fecal Prevalence of Antimicrobial-Resistant Escherichia coli
Aperce, C. C., Amachawadi, R. G. G., Bibber-Krueger, C. L. V., Nagaraja, T. G., Scott, H. M., Vinasco-Torre, J., & Drouillard, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168983 · Cited by 19
The Co-occurrence of NDM-5, MCR-1, and FosA3-Encoding Plasmids Contributed to the Generation of Extensively Drug-Resistant Klebsiella pneumoniae
Zhou, Y., Ai, W., Cao, Y., Guo, Y., Wu, X., Wang, B., Rao, L., Xu, Y., Zhao, H., Wang, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.811263 · Cited by 18
Synthesis and structure elucidation of ZnFe2O4/IRMOF-3/GO for the drug delivery of tetracycline and evaluation of their antibacterial activities
Sanaei-Rad, S., Ghasemzadeh, M. A., & Aghaei, S. S. (2021) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2021.122221 · Cited by 17
Absence of an Interaction Between Tigecycline and Digoxin in Healthy Men
Zimmerman, J. J., Harper, D. M., Matschke, K. T., Speth, J., Raible, D. G., & Fruncillo, R. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.6.835 · Cited by 16
Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
Vaudaux, P. E., Fleury, B., Gjinovci, A., Huggler, E., Bento, M., & Lew, D. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01612-08 · Cited by 16
Minocycline and tigecycline form higher-order Ca2+ complexes of stronger affinity than tetracycline
Arias, K., Robinson, S. G., Lyngaas, S. S., Cherala, S. S., Hartzell, M., Mei, S., Vilic, A., Girel, J. K., Kuemmell, A., Vrettos, J. S., et al. (2015) · Inorganica Chimica Acta · doi:10.1016/j.ica.2015.10.037 · Cited by 15
Efflux Pump Inhibitors Derived From Natural Sources as Novel Antibacterial Agents Against Pseudomonas aeruginosa: A Review
Islamieh, D. I., Afshar, D., Yousefi, M., & Esmaeili, D. (2018) · International Journal of Medical Reviews · doi:10.29252/ijmr-050303 · Cited by 15
Contribution of Hospital Wastewater to the Spread of Antibiotic Resistance in Comparison to Non - Health Institution
Elmanama, A. A., Kichaoui, A. Y. E., & Mohsin, M. (2006) · Cited by 15
A Comprehensive Review of Antibiotics and Antimicrobial Resistance in the Aquaculture Sector of the World and Bangladesh
Afroze, S., Faisal, M., Khan, M. N. A., & Barua, H. (2025) · International Journal of Microbiology · doi:10.1155/ijm/8818516 · Cited by 15
Prevalence of Antimicrobial Resistance in Escherichia coli Strains Isolated from Fishery Workers
Shin, H.-H., & Cho, S.-H. (2013) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2013.03.001 · Cited by 13
Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019
Huband, M. D., Thompson, J. D., Gurung, N. D., Liu, Q., Li, L., Zhang, J., Streit, J. M., & Castanheira, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-21 · Cited by 14
Multidrug Efflux Pumps and Their Inhibitors Characterized by Computational Modeling
Ramaswamy, V. K., Cacciotto, P., Malloci, G., Ruggerone, P., & Vargiu, A. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_30 · Cited by 12
Meta-analysis and empirical research on the effectiveness of biochar in remediating tetracyclines pollution in water bodies
Li, N., Zhu, X., Miao, Y., Wang, Z., Lin, C. S. K., & Li, C. (2025) · Bioresource Technology · doi:10.1016/j.biortech.2025.132917 · Cited by 13
Fighting bacterial resistance: approaches, challenges, and opportunities in the search for new antibiotics.Part 1. Antibiotics used in clinical practice: mechanisms of action and the development of bacterial resistance
ZHIVICH, A. B. (2017) · Microbiology Independent Research Journal (MIR Journal) · doi:10.18527/2500-2236-2017-4-1-31-51 · Cited by 12
Cytotoxicity and Cellular Accumulation of Palladium(II) Complexes of Tetracyclines
Paula, F. C. S. D., Guerra, W., Silva, I. R., Silveira, J. N., Botelho, F. V., Vieira, L. Q., & Pereira-Maia, E. C. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890193 · Cited by 12
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae , Including Molecularly Characterized Strains
Mendes, R. E., Rhomberg, P. R., Lister, T., Cotroneo, N. S., Parr, T. R., & Castanheira, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-20 · Cited by 10
The preparation of hybrid silicon quantum dots by one-step synthesis for tetracycline detection and antibacterial applications
Chi, Y., Sun, W., Zhou, L., Pei, S., Zeng, H., Cheng, Y., & Chai, S. (2023) · Analytical Methods · doi:10.1039/d2ay02102a · Cited by 9
Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker
Ziółkowski, H. (2023) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2023.100493 · Cited by 9
RESISTANCE TO TETRACYCLINE IN ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS: BRIEF OVERVIEW ON MECHANISMS OF RESISTANCE AND EPIDEMIOLOGY
Velhner, M., & Milanov, D. S. (2016) · Archives of Veterinary Medicine · doi:10.46784/e-avm.v8i1.103 · Cited by 9
Tigecycline in vitro Activity against Gram-Negative and Gram-Positive Pathogens Collected in Italy
Roveta, S., Marchese, A. E., & Debbia, E. A. (2007) · Chemotherapy · doi:10.1159/000112415 · Cited by 9
Fluorimetric determination of tetracycline antibiotics in animal derived foods using boron and nitrogen co-doped ceria-based nanoparticles
Li, Q., Fan, P., Hao, Z., Ni, S., Wu, Q., & Li, L. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06214-6 · Cited by 8
Therapeutic Limitations due to Antibiotic Drug Resistance: Road to Alternate Therapies
(2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608059126114030004 · Cited by 8
Proteus penneri
Cantón, R., Sánchez-Moreno, M. P., & Reilly, M. I. M. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13094272 · Cited by 8
Newer antibiotics for the treatment of respiratory tract infections
Blasi, F., Tarsia, P., Cosentini, R., & Valenti, V. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200405000-00008 · Cited by 8
Prevalence of antibiotic resistance genes in bacteria from Gomti and Ganga rivers: implications for water quality and public health
Naznine, F., Ansari, M. I., Aafreen, U., Singh, K., Verma, R., Dey, M., Malik, Y. S., & Khubaib, M. (2024) · Environmental Monitoring and Assessment · doi:10.1007/s10661-024-13114-y · Cited by 7
Optimization of tigecycline dosage regimen for different infections in the patients with hepatic or renal impairment
Li, M. X., Li, N., Zhu, L., & Liu, W. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1800318 · Cited by 7
A Natural Lipotrisaccharide and Its Derivatives Selectively Lyse Streptococcus pneumoniae via Interaction with Cell Membrane
Liu, B., Liu, X., Zhang, J., & Liu, G. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00008 · Cited by 6
Tetracycline-ferrite nanocomposites formed via high-energy ball milling and the influence of milling conditions
Branham, M. L., Moyo, T., Abdallah, H. M. I., & Masina, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.017 · Cited by 6
Multidrug resistance and major facilitator superfamily antimicrobial efflux pumps of the ESKAPEE pathogen Staphylococcus aureus
Aborah, E., Ayitah, M., Boafo, K. F., Ortiz-Alegria, A., Lekshmi, M., Dhanush, C. K., Kumar, S. H., & Varela, M. F. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100897 · Cited by 5
Characterization and Isolation of the Major Biologically Active Metabolites Isolated from Ficus retusa and Their Synergistic Effect with Tetracycline against Certain Pathogenic-Resistant Bacteria
Alqahtani, A., Marrez, D. A., Aleraky, M., Fagir, N. A., Alqahtani, O. S., Othman, S., Raey, M. A. E., & Attia, H. G. (2022) · Pharmaceuticals · doi:10.3390/ph15121473 · Cited by 5
Secondary Metabolites and Toxins of Microbial Origin for the Treatment of Diseases
Baria, D., Shah, U., Egbuna, C., & Mtewa, A. G. (2020) · doi:10.1002/9781119650034.ch11 · Cited by 5
Tetracyclines and Tetracycline Derivatives
Nelson, M. L., & Levy, S. B. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00210-5 · Cited by 4

Authors: Chopra, I.
Affiliations: University of Leeds (GB)
Corresponding author: Chopra, Ian
Venue: Drug Resistance Updates
Publisher: Elsevier BV
Published: 2002-06
Volume: 5
Issue: 3-4
Pages: 119-125
ISSN: 1368-7646 (ISSN-L)
DOI: 10.1016/s1368-7646(02)00051-1
OpenAlex: W1970691146
Cited by: 143
References: 42
Citations by year: 2026: 4 · 2025: 6 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 9
FWCI: 3.50
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug Resistance Updates (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords: tetracycline, glycylcyclines, tigecycline, antibiotic resistance, efflux pumps, multidrug resistance, Gram-positive bacteria, combination therapy
MeSH terms: Tigecycline, Humans, Microbial Sensitivity Tests, Minocycline, Structure-Activity Relationship, Tetracycline Resistance, Tetracyclines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks